JPY 1039.0
(0.19%)
Breakdown | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Operating Cash Flow | 127.93 Million | 286.38 Million | -32.82 Million | 186.17 Million |
Net Income | 266.75 Million | 191.35 Million | 135.57 Million | 54.93 Million |
Depreciation & Amortization | 19.83 Million | 20.29 Million | 18.9 Million | 18.98 Million |
Deferred income taxes | - | - | - | - |
Stock-based compensation | - | - | - | - |
Change in working capital | -48.55 Million | 22.5 Million | -80.21 Million | 79.89 Million |
Other non-cash items | -22.05 Million | 69.01 Million | -37.72 Million | 30.33 Million |
Investing Cash Flow | -285.53 Million | -29.82 Million | -89.69 Million | -29.82 Million |
Investments in PPE | -294.99 Million | -19.95 Million | -66.9 Million | -11.97 Million |
Acquisitions | - | - | - | - |
Investment purchases | -7.17 Million | -8.41 Million | -14.74 Million | -4.83 Million |
Sales/Maturities of investments | 18.47 Million | 4.05 Million | - | - |
Other Investing Activities | -1.83 Million | -5.51 Million | -8.05 Million | -13.01 Million |
Financing Cash Flow | 81.89 Million | 159.66 Million | 10.69 Million | 77.34 Million |
Debt repayment | -107.95 Million | -57 Million | -3 Million | -86.76 Million |
Dividends payments | -20.58 Million | -17.79 Million | -17.04 Million | -5.68 Million |
Common Stock Repurchased | - | - | - | - |
Common Stock Issuance | - | 240.28 Million | 30 Million | - |
Other Financing Activities | -2000.00 | -1000.00 | -1000.00 | -1000.00 |
Accounts receivables | -116 Million | -42 Million | - | - |
Accounts payables | - | - | - | - |
Inventory | 15.67 Million | -3.16 Million | -6.22 Million | 85 Thousand |
Other working capital | -21 Million | 95 Million | - | - |
Cash at beginning of period | 858.37 Million | 442.15 Million | 553.98 Million | 320.28 Million |
Cash at end of period | 782.67 Million | 858.37 Million | 442.15 Million | 553.98 Million |
Capital Expenditure | -294.99 Million | -19.95 Million | -66.9 Million | -11.97 Million |
Effect of forex changes on cash | - | - | - | - |
Net cash flow / Change in cash | -75.69 Million | 416.21 Million | -111.83 Million | 233.69 Million |
Free Cash Flow | -167.05 Million | 266.42 Million | -99.73 Million | 174.19 Million |
Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -64 Million | 266.75 Million | 56 Million | 80 Million | 61 Million | 5 Million |
Depreciation & Amortization | - | 19.83 Million | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | -48.55 Million | - | - | - | - |
Other non-cash items | 64 Million | -22.05 Million | -56 Million | -80 Million | -61 Million | -5 Million |
Investing Cash Flow | - | -285.53 Million | - | - | - | - |
Investments in PPE | - | -294.99 Million | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | -7.17 Million | - | - | - | - |
Sales/Maturities of investments | - | 18.47 Million | - | - | - | - |
Other Investing Activities | - | -1.83 Million | - | - | - | - |
Financing Cash Flow | - | 81.89 Million | - | - | - | - |
Debt repayment | - | -107.95 Million | - | - | - | - |
Dividends payments | - | -20.58 Million | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | -2000.00 | - | - | - | - |
Accounts receivables | - | -116 Million | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | 15.67 Million | - | - | - | - |
Other working capital | - | -21 Million | - | - | - | - |
Cash at beginning of period | - | 858.37 Million | - | - | - | - |
Cash at end of period | - | 782.67 Million | - | - | - | - |
Capital Expenditure | - | -294.99 Million | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | -75.69 Million | - | - | - | - |
Free Cash Flow | - | -167.05 Million | - | - | - | - |
CIWT
7704
AVCT
TPG
CDLX
300850